Alteogen, a Kosdaq-listed biotech company, said it has made an amendment to its existing license agreement with the global pharmaceutical company MSD, known as Merck & Co. in the U.S. and Canada.The revised agreement grants MSD exclusive global rights to ALT-B4, a recombinant human hyaluronidase enz
Samsung Bioepis said it has made significant progress with its autoimmune disease treatment biosimilar, SB17, suggesting its potential use across all indications treatable by the original drug, Stelara.Stelara is an interleukin (IL)-12, 23 inhibitor developed by Janssen. It is used to treat inflamma
In a move to combat the rising threat of cardiovascular disease (CVD) in the Asia-Pacific region, Korea Biomedical Review (KBR) has announced its partnership with the APAC CVD Alliance on Thursday. Yang Kyung-cheol, CEO and publisher of KBR, and Dr. Krishna Reddy Nallamalla, CEO of ACCESS Health Int
As tensions between the U.S. and China in the healthcare industry escalate, the U.S. is intensifying its scrutiny of Chinese companies, extending beyond the biotech sector into medical devices.The U.S. FDA has recently issued a warning to medical device manufacturers to re-examine the work of third-
Korean medical experts have welcomed the introduction of Pfizer’s Zavicefta (ingredient: ceftazidime/avibactam), a new antibiotic treatment for infections caused by multi-drug resistant organisms, including carbapenem-resistant Enterobacteriaceae (CRE).During a press conference organized by Pfizer K
In the midst of a deepening dispute between the Korean government and medical professionals over medical school quotas, an unprecedented number of resident doctors and medical students are turning their attention to the United States Medical Licensing Examination (USMLE), signaling a potential mass
In what's quickly become the talk of the town—or rather, the chirp of the medical community—the Vice Minister of Health and Welfare Park Min-soo has ruffled more than a few feathers with a slip of the tongue that has doctors across the nation tweeting with outrage and bemusement.During a recent brie
MediThinQ, a company focusing on medical augmented reality (AR) technology, has announced a strategic partnership with Medtronic to introduce the AR wearable display, Scopeye, into the U.S. market.At a press conference on Wednesday, MediThinQ CEO Im Seung-joon detailed the collaboration's objectives
The Ministry of Food and Drug Safety announced a three-month manufacturing suspension for Celltrion Pharm's Astection Enteric Coated Tablets 100mg (aspirin), effective from Feb. 27 to May 26, due to violations of the Pharmaceutical Affairs Act.The medication is used for preventing thrombosis in cond
On Monday, trainee doctors at Korea’s so-called “Big 5” hospitals submitted a wave of resignations, despite the government’s threat to suspend their medical licenses if they do not return to work.The five largest hospitals are Seoul National University Hospital, Samsung Medical Center, Asan Medical
Seegene, once hailed as a beneficiary of the Covid-19 pandemic, has reported a significant deterioration in profitability due to a drastic decline in related sales as the world transitions to the endemic phase of the virus.The company announced its preliminary financial results for 2023 last Friday,
VUNO said it has entered into a strategic partnership with DRGEM to embed VUNO's advanced AI solutions into DRGEM's X-ray systems.Under the agreement, VUNO will supply its AI-based thoracic X-ray interpretation assistant solution, VUNOMED Chest X-ray, to DRGEM.VUNOMED Chest X-ray stands out as an AI
In recent years, Korea's market for pediatric growth hormone treatments has witnessed a significant surge, with non-reimbursable treatments accounting for 90 percent of the total prescriptions. According to IQVIA, a drug market research firm, the pediatric growth hormone treatment market grew to 238
A research team at Yongin Severance Hospital has demonstrated the effectiveness of ChatGPT, specifically the GPT-4 model, in accurately predicting cardiovascular diseases.GPT-4, the latest iteration of the ChatGPT series developed by OpenAI, has previously garnered attention for passing the United S
Daewoong Pharmaceutical's Fexuclue is expanding globally as fast as it is effective.Daewoong said Friday that its gastroesophageal reflux disease (GERD) treatment, Fexuclue, has entered or is about to enter the market in 24 countries, including Korea, in just one year and six months since its launch
Lunit announced a record-breaking revenue of 25 billion won ($21 million) for 2023, marking an 80.9 percent increase from 13.8 billion won a year earlier, thanks to a continued expansion of overseas sales of medical AI solutions. Last year, the Kosdaq-listed company posted an operating loss of appro
In a controversial move, the Korean government announced a plan to increase the admission quota for medical schools by 2,000 students on Feb. 6, sparking fierce opposition from the medical community, including the Korean Medical Association (KMA) and other healthcare organizations.The medical commun
Celltrion is expanding its market presence in Peru, a key Latin American market, with successful public tender wins.Celltrion’s Truxima 500mg (rituximab) won the tender for the Peruvian Ministry of Health (Centro Nacional de Abastecimiento de Recursos Estratégicos en Salud, CENARES), the largest pub
Dong-A ST and IMBiologics said they have entered into a research collaboration agreement to develop a novel antibody drug candidate.The collaboration involves IMBiologics deploying its ePENDY (enhanced/engineered Pentamer body) platform technology.Unlike the conventional IgG antibody-based modalitie
Korean bio ventures are increasingly withdrawing their initial public offerings (IPOs) voluntarily after the stock market regulator Korea Exchange (KRX) has taken steps to implement a more rigorous review process.Most recently, Pinotbio voluntarily withdrew its Kosdaq listing plan on Wednesday, nine